<

 
Data updated 2025-10-29 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date22835249.8 (espacenet)  (Federated)  (European Patent Register), 20221208
Patent/reg. no. and dateDK/EP 4426307, 20250702
Publication date20240911
Priority no. and dateUS 202163287642 P, 20211209, EP 21218202, 20211229, EP 22177750, 20220608
EP pub. no. and date EP 4426307 20240911
Effective date
Applicant/ownerBoehringer Ingelheim International GmbH, Binger Strasse 173
55216 Ingelheim am Rhein, DE
Applicant ref. no.2026580
InventorHESSLINGER, Christian,
55216 Ingelheim am Rhein, DE,
BAUER, Verena,
55216 Ingelheim am Rhein, DE,
BOSSERT, Sebastian Martin,
55216 Ingelheim am Rhein, DE,
NICKOLAUS, Peter,
55216 Ingelheim am Rhein, DE,
KOBER, Susan,
55216 Ingelheim am Rhein, DE,
LIU, Yi,
Ridgefiled, Connecticut 06877-0368, US,
SARNO, Maria,
55216 Ingelheim am Rhein, DE,
VOSS, Florian,
55216 Ingelheim am Rhein, DE
RepresentativeRWS Group, RWS Compass House Vanwall Business Park, Vanwall Road Maidenhead, Berkshire SL6 4UB, GB
Opponent
IPC ClassA61K 31/519 (2006.01) , A61P 11/00 (2006.01) 
TitleNY ORAL FARMACEUTISK SAMMENSÆTNING OG DOSERINGSPLAN TIL BEHANDLING AF PROGRESSIVE FIBROSERENDE INTERSTITIELLE LUNGESYGDOMME
Int. application no.EP2022084968
Int. publication no.WO2023104958
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact